“…Intermittent hypoxic training is a non-pharmacologic and systemic therapy that has a wide spectrum of beneficial effects against major diseases/disorders in humans, such as metabolic, cardiovascular, and neurodegenerative ailments. For example, intermittent hypoxic training resulted in augmentation of hypoxic sensitivity and significant decrease in blood concentration of DOPA in the patients with Parkinson’s disease [ 27 ], improved collective inspiratory muscle activity in patients with amyotrophic lateral sclerosis [ 28 ], increased cerebral blood flow in patients with heart failure [ 29 ], provided cardiovascular benefits in elderly people [ 30 ], decreased systolic blood pressure in patients with hypertension [ 31 , 32 ], upregulated erythropoietin [ 33 , 34 ], improved cognitive performance and quality of life in old people [ 35 ], alleviated surgery trauma [ 36 ], diminished oxidative stress [ 37 ], and normalized blood insulin levels in pre-diabetic patients [ 38 ]. Nevertheless, some pathological forms of intermittent hypoxia, e.g., severe obstructive sleep apnea (OSA), may induce destructive consequences in the body, including mitochondrial dysregulation, acidosis, altered mitochondrial membrane permeability, and impaired ATP biosynthesis [ 39 ], leading to impairment in attention, memory, and executive function and acceleration of AD development, along with cardiovascular injuries [ 40 ].…”